450.01(13v)(a)(a) The drug binds to the opioid receptors and competes with or displaces opioid agonists at the opioid receptor site but does not activate the receptors, effectively blocking the receptor and preventing or reversing the effect of an opioid agonist. 450.01(13w)(13w) “Out-of-state 3rd-party logistics provider” means a person located outside this state that contracts with a prescription drug manufacturer to provide or coordinate warehousing, distribution, or other services within this state on behalf of the manufacturer but that does not take title to the manufacturer’s prescription drug or have general responsibility to direct the prescription drug’s sale or disposition. 450.01(14)(14) “Patient” means the person or other animal for whom drug products or devices are prescribed or to whom drug products or devices are dispensed or administered. 450.01(14m)(14m) “Pedigree” means a document or electronic file containing information that records each distribution of a prescription drug. 450.01(15g)(15g) “Pharmacy technician” means a person registered by the board under s. 450.068. 450.01(15m)(15m) “Pharmacy warehouse” means a physical location for prescription drugs that acts as a central warehouse and performs intracompany sales. 450.01(15t)(15t) “Practice of a pharmacy technician” means any of the following: 450.01 NoteNOTE: Sub. (15t) was created as sub. (16c) by 2021 Wis. Act 100 and renumbered to sub. (15t) by the legislative reference bureau under s. 13.92 (1) (bm) 2. 450.01(16)(16) “Practice of pharmacy” means any of the following: 450.01(16)(b)(b) Compounding, packaging, labeling, dispensing and the coincident distribution of drugs and devices. 450.01(16)(d)(d) Proper and safe storage of drugs and devices and maintaining proper records of the drugs and devices. 450.01(16)(e)(e) Providing information on drugs or devices which may include, but is not limited to, advice relating to therapeutic values, potential hazards and uses. 450.01(16)(g)(g) Supervision of pharmacy technicians and other pharmacist supportive personnel. 450.01(16)(h)(h) Making therapeutic alternate drug selections, if made in accordance with written guidelines or procedures previously established by a pharmacy and therapeutics committee of a hospital and approved by the hospital’s medical staff and use of the therapeutic alternate drug selection has been approved for a patient during the period of the patient’s stay within the hospital by any of the following: 450.01(16)(h)2.2. The patient’s advanced practice nurse prescriber, if the advanced practice nurse prescriber has entered into a written agreement to collaborate with a physician. 450.01(16)(hm)(hm) Making therapeutic alternate drug selections in accordance with written guidelines or procedures previously established by a quality assessment and assurance committee of a nursing facility under s. 49.498 (2) (a) 3. or by a committee established for a nursing home under s. 50.045 (2), if the use of the therapeutic alternate drug selection has been approved for a patient during the period of the patient’s stay within the nursing facility or nursing home by any of the following: 450.01(16)(hr)(hr) Making therapeutic alternate drug selections in accordance with written guidelines or procedures previously established in rules promulgated by the corrections system formulary board under s. 301.103, if the use of the therapeutic alternate drug selection has been approved for a prisoner, as defined in s. 301.01 (2), during his or her period of confinement in a state correctional institution, as defined in s. 301.01 (4), by any of the following: